fbpx

Watch Now:  ReSPECT™ Glioblastoma Clinical Trial Update Webinar

Delivering More For Patients

POSITIVELY IMPACTING HEALTHCARE

We are committed to developing breakthrough treatments that provide improved safety, efficacy, and convenience for patients battling rare cancers.  

Seeing New Possibilities

GIVING PROVEN THERAPIES NEW LIFE

Our proprietary nanotechnology platform reformulates and delivers approved chemotherapy and widely-used radiotherapy to help people lead longer and healthier lives.

Standing Up To Brain Cancer

DEFYING ODDS ONE PATIENT AT A TIME

Our transformative approach to targeting and eliminating recurrent tumors locally and precisely while reducing side effects systemically means more time in the sun.

Outlasting Lung Cancer

MAKING EACH BREATH COUNT

We strive to help patients spend less time in an infusion center receiving treatment and more time laughing, living, and sharing precious moments with friends and family.

Delivering More For Patients

POSITIVELY IMPACTING HEALTHCARE

We are committed to developing breakthrough treatments that provide improved safety, efficacy, and convenience for patients battling rare cancers.  

Seeing New Possibilities

GIVING PROVEN THERAPIES NEW LIFE

Our proprietary nanotechnology platform reformulates and delivers approved chemotherapy and widely-used radiotherapy to help people lead longer and healthier lives.

Standing Up To Brain Cancer

DEFYING ODDS ONE PATIENT AT A TIME

Our transformative approach to targeting and eliminating recurrent tumors locally and precisely while reducing side effects systemically means more time in the sun.

Outlasting Lung Cancer

MAKING EACH BREATH COUNT

We strive to help patients spend less time in an infusion center receiving treatment and more time laughing, living, and sharing precious moments with friends and family.

Delivering More For Patients

POSITIVELY IMPACTING HEALTHCARE

We are committed to developing breakthrough treatments that provide improved safety, efficacy, and convenience for patients battling rare cancers.  

Seeing New Possibilities

GIVING PROVEN THERAPIES NEW LIFE

Our proprietary nanotechnology platform reformulates and delivers approved chemotherapy and widely-used radiotherapy to help people lead longer and healthier lives.

Standing Up To Brain Cancer

DEFYING ODDS ONE PATIENT AT A TIME

Our transformative approach to targeting and eliminating recurrent tumors locally and precisely while reducing side effects systemically means more time in the sun.

Outlasting Lung Cancer

MAKING EACH BREATH COUNT

We strive to help patients spend less time in an infusion center receiving treatment and more time laughing, living, and sharing precious moments with friends and family.

USING INNOVATIONS TO ADDRESS LIFE-THREATENING DISEASES

Watch The Experts

“New treatments for (recurrent glioblastoma) are critical to making an impact for these patients.”

Marc Hedrick, MD
President & Chief Executive Officer of Plus Therapeutics

“Radiation has made the biggest dent in terms of how long people live.”

Andrew Brenner, MD PhD
Principal Investigator of U.S. NIH/NCI-Supported Phase 1 Clinical Trial
Mays Cancer Center / UT Health San Antonio MD Anderson Cancer Center

Development Is In Our DNA

There are many reasons why we believe we possess the capacity and experience to develop and manufacture large-scale, sophisticated nanotechnology-encapsulated cytotoxic drugs that successfully meet patient needs around the globe:

A fully GMP-compliant, validated, state-of-the-art, U.S. development and manufacturing facility supported by an ICH-compliant Quality Management System.

A 10,000 square foot space with ISO Class 7 and 8 cleanrooms, including a negative pressure room for managing hazardous drugs.

A dedicated analytical chemistry lab with multiple High Performance Liquid Chromatography (HPLC) systems with multiple detector capability, an environmental monitoring lab, and a fully qualified Water For Injection (WFI) system onsite. 

Decades of drug delivery development experience with combination products and liposomal encapsulation, resulting in the completion of multiple successful clinical trials in the U.S. and internationally.

Selective Tumor Targeting

While nanotechnology-based drug delivery systems have been used clinically for some time, not all of them are equally effective.  We are taking a unique design approach with widely-used chemotherapy drugs, using our patented liposomal formulation to elevate drug delivery and performance.

DocePLUS Product Candidate